EPHB4 Mutation Implicated in Capillary Malformation-Arteriovenous Malformation Syndrome: A Case Report

Area of Science:

• Genetics
• Molecular Biology
• Vascular Biology

Background:

• Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is a vascular disorder characterized by skin and deeper vascular abnormalities.
• Mutations in the RASA1 gene are identified in approximately 68% of CM-AVM syndrome cases.
• The genetic basis for CM-AVM syndrome in patients without RASA1 mutations remains largely unknown.

Observation:

• A case of RASA1-negative CM-AVM syndrome in a child was investigated.
• A de novo missense mutation in the EPHB4 gene was identified in this patient.
• EPHB4 encodes a transmembrane tyrosine kinase receptor crucial for blood vessel development.

Findings:

• The identified EPHB4 mutation is inactivating.
• Inactivating EPHB4 mutations were shown to upregulate the MAPK and mTORC1 pathways.
• These pathway alterations may contribute to the development of vascular malformations.

Implications:

• This study identifies EPHB4 as a novel gene associated with CM-AVM syndrome.
• The findings expand the understanding of the genetic etiology of CM-AVM.
• Targeting the MAPK and mTORC1 pathways could be a potential therapeutic strategy for CM-AVM.